SABRA HEALTH CARE REIT INC (SBRA) Fundamental Analysis & Valuation
NASDAQ:SBRA • US78573L1061
Current stock price
19.57 USD
-0.52 (-2.59%)
At close:
19.5156 USD
-0.05 (-0.28%)
After Hours:
This SBRA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SBRA Profitability Analysis
1.1 Basic Checks
- In the past year SBRA was profitable.
- SBRA had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: SBRA reported negative net income in multiple years.
- In the past 5 years SBRA always reported a positive cash flow from operatings.
1.2 Ratios
- With a decent Return On Assets value of 2.83%, SBRA is doing good in the industry, outperforming 72.95% of the companies in the same industry.
- SBRA has a Return On Equity of 5.51%. This is in the better half of the industry: SBRA outperforms 68.03% of its industry peers.
- SBRA's Return On Invested Capital of 3.88% is fine compared to the rest of the industry. SBRA outperforms 72.13% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for SBRA is in line with the industry average of 3.12%.
- The last Return On Invested Capital (3.88%) for SBRA is above the 3 year average (3.71%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.83% | ||
| ROE | 5.51% | ||
| ROIC | 3.88% |
ROA(3y)1.83%
ROA(5y)0.45%
ROE(3y)3.54%
ROE(5y)0.95%
ROIC(3y)3.71%
ROIC(5y)3.47%
1.3 Margins
- SBRA's Profit Margin of 20.09% is fine compared to the rest of the industry. SBRA outperforms 72.95% of its industry peers.
- SBRA's Profit Margin has declined in the last couple of years.
- With a decent Operating Margin value of 34.06%, SBRA is doing good in the industry, outperforming 70.49% of the companies in the same industry.
- SBRA's Operating Margin has declined in the last couple of years.
- With a Gross Margin value of 66.87%, SBRA perfoms like the industry average, outperforming 47.54% of the companies in the same industry.
- In the last couple of years the Gross Margin of SBRA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.06% | ||
| PM (TTM) | 20.09% | ||
| GM | 66.87% |
OM growth 3Y-3.2%
OM growth 5Y-4.77%
PM growth 3YN/A
PM growth 5Y-2.77%
GM growth 3Y-4.64%
GM growth 5Y-4.04%
2. SBRA Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SBRA is destroying value.
- Compared to 1 year ago, SBRA has more shares outstanding
- The number of shares outstanding for SBRA has been increased compared to 5 years ago.
- Compared to 1 year ago, SBRA has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 0.94, we must say that SBRA is in the distress zone and has some risk of bankruptcy.
- SBRA's Altman-Z score of 0.94 is fine compared to the rest of the industry. SBRA outperforms 71.31% of its industry peers.
- A Debt/Equity ratio of 0.90 indicates that SBRA is somewhat dependend on debt financing.
- SBRA's Debt to Equity ratio of 0.90 is fine compared to the rest of the industry. SBRA outperforms 63.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.9 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.94 |
ROIC/WACC0.54
WACC7.14%
2.3 Liquidity
- A Current Ratio of 1.48 indicates that SBRA should not have too much problems paying its short term obligations.
- With a decent Current ratio value of 1.48, SBRA is doing good in the industry, outperforming 72.13% of the companies in the same industry.
- SBRA has a Quick Ratio of 1.48. This is a normal value and indicates that SBRA is financially healthy and should not expect problems in meeting its short term obligations.
- SBRA's Quick ratio of 1.48 is fine compared to the rest of the industry. SBRA outperforms 73.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.48 |
3. SBRA Growth Analysis
3.1 Past
- SBRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.75%, which is quite impressive.
- Measured over the past years, SBRA shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.91% on average per year.
- The Revenue has grown by 10.15% in the past year. This is quite good.
- Measured over the past years, SBRA shows a small growth in Revenue. The Revenue has been growing by 5.29% on average per year.
EPS 1Y (TTM)20.75%
EPS 3YN/A
EPS 5Y-0.91%
EPS Q2Q%-42.11%
Revenue 1Y (TTM)10.15%
Revenue growth 3Y7.43%
Revenue growth 5Y5.29%
Sales Q2Q%16.21%
3.2 Future
- SBRA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.11% yearly.
- SBRA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.91% yearly.
EPS Next Y15.21%
EPS Next 2Y10.92%
EPS Next 3Y9.11%
EPS Next 5YN/A
Revenue Next Year11.84%
Revenue Next 2Y10.45%
Revenue Next 3Y9.97%
Revenue Next 5Y11.91%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. SBRA Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 30.58, SBRA can be considered very expensive at the moment.
- 67.21% of the companies in the same industry are more expensive than SBRA, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of SBRA to the average of the S&P500 Index (27.79), we can say SBRA is valued inline with the index average.
- SBRA is valuated quite expensively with a Price/Forward Earnings ratio of 26.54.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of SBRA indicates a rather cheap valuation: SBRA is cheaper than 83.61% of the companies listed in the same industry.
- SBRA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 38.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.58 | ||
| Fwd PE | 26.54 |
4.2 Price Multiples
- SBRA's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. SBRA is more expensive than 61.48% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 16.69 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.01
PEG (5Y)N/A
EPS Next 2Y10.92%
EPS Next 3Y9.11%
5. SBRA Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 5.81%, SBRA is a good candidate for dividend investing.
- SBRA's Dividend Yield is a higher than the industry average which is at 7.46.
- SBRA's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.81% |
5.2 History
- The dividend of SBRA decreases each year by -2.44%.
- SBRA has paid a dividend for at least 10 years, which is a reliable track record.
- SBRA has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-2.44%
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
- 186.04% of the earnings are spent on dividend by SBRA. This is not a sustainable payout ratio.
DP186.04%
EPS Next 2Y10.92%
EPS Next 3Y9.11%
SBRA Fundamentals: All Metrics, Ratios and Statistics
19.57
-0.52 (-2.59%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-12 2026-02-12/amc
Earnings (Next)04-29 2026-04-29
Inst Owners105.32%
Inst Owner Change-0.01%
Ins Owners1.1%
Ins Owner Change6.47%
Market Cap4.93B
Revenue(TTM)774.63M
Net Income(TTM)155.61M
Analysts76
Price Target22.28 (13.85%)
Short Float %11.15%
Short Ratio10.45
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.81% |
Yearly Dividend1.18
Dividend Growth(5Y)-2.44%
DP186.04%
Div Incr Years0
Div Non Decr Years2
Ex-Date02-13 2026-02-13 (0.3)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-44.68%
Min EPS beat(2)-51.75%
Max EPS beat(2)-37.61%
EPS beat(4)1
Avg EPS beat(4)-10.49%
Min EPS beat(4)-51.75%
Max EPS beat(4)51.26%
EPS beat(8)2
Avg EPS beat(8)-12.84%
EPS beat(12)2
Avg EPS beat(12)-37.62%
EPS beat(16)3
Avg EPS beat(16)-70.46%
Revenue beat(2)1
Avg Revenue beat(2)6.1%
Min Revenue beat(2)-0.25%
Max Revenue beat(2)12.46%
Revenue beat(4)3
Avg Revenue beat(4)3.96%
Min Revenue beat(4)-0.25%
Max Revenue beat(4)12.46%
Revenue beat(8)7
Avg Revenue beat(8)2.98%
Revenue beat(12)8
Avg Revenue beat(12)2%
Revenue beat(16)10
Avg Revenue beat(16)1.09%
PT rev (1m)1.43%
PT rev (3m)4.8%
EPS NQ rev (1m)-1.1%
EPS NQ rev (3m)-5.81%
EPS NY rev (1m)-3.62%
EPS NY rev (3m)-6.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.58 | ||
| Fwd PE | 26.54 | ||
| P/S | 6.37 | ||
| P/FCF | N/A | ||
| P/OCF | 14.15 | ||
| P/B | 1.75 | ||
| P/tB | 1.79 | ||
| EV/EBITDA | 16.69 |
EPS(TTM)0.64
EY3.27%
EPS(NY)0.74
Fwd EY3.77%
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)1.38
OCFY7.06%
SpS3.07
BVpS11.19
TBVpS10.93
PEG (NY)2.01
PEG (5Y)N/A
Graham Number12.6946 (-35.13%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.83% | ||
| ROE | 5.51% | ||
| ROCE | 4.91% | ||
| ROIC | 3.88% | ||
| ROICexc | 3.93% | ||
| ROICexgc | 3.98% | ||
| OM | 34.06% | ||
| PM (TTM) | 20.09% | ||
| GM | 66.87% | ||
| FCFM | N/A |
ROA(3y)1.83%
ROA(5y)0.45%
ROE(3y)3.54%
ROE(5y)0.95%
ROIC(3y)3.71%
ROIC(5y)3.47%
ROICexc(3y)3.75%
ROICexc(5y)3.51%
ROICexgc(3y)3.78%
ROICexgc(5y)3.54%
ROCE(3y)4.7%
ROCE(5y)4.39%
ROICexgc growth 3Y5.81%
ROICexgc growth 5Y1.97%
ROICexc growth 3Y5.63%
ROICexc growth 5Y2.01%
OM growth 3Y-3.2%
OM growth 5Y-4.77%
PM growth 3YN/A
PM growth 5Y-2.77%
GM growth 3Y-4.64%
GM growth 5Y-4.04%
F-Score5
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.9 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 5.61 | ||
| Cap/Depr | 242.22% | ||
| Cap/Sales | 58.47% | ||
| Interest Coverage | 2.38 | ||
| Cash Conversion | 77.32% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.48 | ||
| Altman-Z | 0.94 |
F-Score5
WACC7.14%
ROIC/WACC0.54
Cap/Depr(3y)121.85%
Cap/Depr(5y)94.04%
Cap/Sales(3y)30%
Cap/Sales(5y)24.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.75%
EPS 3YN/A
EPS 5Y-0.91%
EPS Q2Q%-42.11%
EPS Next Y15.21%
EPS Next 2Y10.92%
EPS Next 3Y9.11%
EPS Next 5YN/A
Revenue 1Y (TTM)10.15%
Revenue growth 3Y7.43%
Revenue growth 5Y5.29%
Sales Q2Q%16.21%
Revenue Next Year11.84%
Revenue Next 2Y10.45%
Revenue Next 3Y9.97%
Revenue Next 5Y11.91%
EBIT growth 1Y2.66%
EBIT growth 3Y4%
EBIT growth 5Y0.26%
EBIT Next Year84.43%
EBIT Next 3Y26.83%
EBIT Next 5Y18.61%
FCF growth 1Y-159.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.26%
OCF growth 3Y3.36%
OCF growth 5Y-0.36%
SABRA HEALTH CARE REIT INC / SBRA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of SABRA HEALTH CARE REIT INC (SBRA) stock?
ChartMill assigns a fundamental rating of 4 / 10 to SBRA.
Can you provide the valuation status for SABRA HEALTH CARE REIT INC?
ChartMill assigns a valuation rating of 2 / 10 to SABRA HEALTH CARE REIT INC (SBRA). This can be considered as Overvalued.
Can you provide the profitability details for SABRA HEALTH CARE REIT INC?
SABRA HEALTH CARE REIT INC (SBRA) has a profitability rating of 5 / 10.
What are the PE and PB ratios of SABRA HEALTH CARE REIT INC (SBRA) stock?
The Price/Earnings (PE) ratio for SABRA HEALTH CARE REIT INC (SBRA) is 30.58 and the Price/Book (PB) ratio is 1.75.
How financially healthy is SABRA HEALTH CARE REIT INC?
The financial health rating of SABRA HEALTH CARE REIT INC (SBRA) is 3 / 10.